Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice
Type 2 diabetes mellitus and its related insulin resistance are known to increase the risk of cancer. Anti-diabetic agents can improve insulin resistance and may lead to the suppression of carcinogenesis. This study aimed to investigate the preventive effects of the alpha-glucosidase inhibitor vogli...
Main Authors: | Junichi Kato, Yohei Shirakami, Taku Mizutani, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Masahito Shimizu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/6/2226 |
Similar Items
-
Preventive and Therapeutic Effect of Voglibose in Management of Diabetes Mellitus
by: V.I. Pankiv
Published: (2014-08-01) -
Voglibose: An Alpha Glucosidase Inhibitor
by: Ajay S. Dabhi, et al.
Published: (2013-12-01) -
Role of Voglibose in the Treatment of Prediabetes in Indian Population: A Cross-Speciality Survey
by: Pavitra Raj Dewda, et al.
Published: (2013-10-01) -
The Efficiency of Using α-glucosidase Inhibitors in Patients with Diabetes Mellitus Type 2 and Obesity
by: N.V. Pasiechko, et al.
Published: (2015-03-01) -
New Therapeutic Possibilities of Type 2 Diabetes Mellitus Management: Experience of Voglibose Application
by: V.I. Pankiv
Published: (2014-09-01)